Lv1
60 积分 2024-06-12 加入
Neoadjuvant Lorlatinib Induces Pathological Complete Response in Advanced ALK-Positive Lung Cancer: A Case Report
9小时前
待确认
Recurrence Risk Following Percutaneous Transthoracic Needle Biopsy in Patients Undergoing Sublobar Resection for Stage I Lung Cancer
15小时前
已完结
Sugemalimab for Post-PD-1 Progression in Non-small Cell Lung Cancer
1个月前
已完结
Vitamin D Use and Mortality in Chronic Kidney Disease: Immortal Time Bias
3个月前
已完结
目标仿真试验临床研究应用规范专家共识（2025版）
5个月前
已完结
临床研究中混杂偏倚控制的原则和方法
5个月前
已完结
Bias in observational studies
5个月前
已完结
Current Biomarkers of IgA Nephropathy
5个月前
已完结
Anti-nephrin antibodies in patients with IgA nephropathy and nephrotic syndrome
8个月前
已完结
皖公网安备34019202002308
